Posts

ASCO23: ‘Safety & efficacy of the novel BRAF inhibitor ...

MIAMI, FLORIDA (EMBARGOED UNTIL MAY 25, 2023, AT 5 P.M. ET) – An early-phase stu...

Rotman School professor honored for contributions to th...

 Toronto – Anita M. McGahan, a professor at the University of Toronto’s Rotman S...

New study explores how exposure to mix of toxic metals ...

Chronic kidney disease is a growing problem worldwide and in the aging U.S. popu...

Long-duration energy storage: the time is now

By Courtney Stenson Credit: Image by Stephanie King | Pacific Northwest National...

Plants remove cancer causing toxins from air

A ground-breaking study has revealed that plants can efficiently remove toxic ga...

A celebration of artificial light sources

Did you know that until the early twentieth century, artificial light sources on...

‘Noise-cancelling’ qubits developed at UChicago to mini...

Despite their immense promise to solve new kinds of problems, today’s quantum co...

New variation of the once-obsolete streptothricin shows...

Scientists have been on the lookout for antibiotics against multidrug-resistant ...

Krystal Biotech Gains FDA Green Light For Skin-Disorder...

Vyjuvek, a medication developed by Krystal Biotech, has become the first therapy...

Sanofi finds success in clinical trial for smoker’s lungs

Sanofi has emphasized the rapid and sustained benefits of its collaborative anti...

FTC sues to block Amgen’s $27.8B deal for Horizon

The Federal Trade Commission (FTC) is questioning Amgen’s $27.8 billion acquisit...

Inovio’s INO-3107 receives orphan drug status from EC

INO-3107 also received orphan drug designation from the US Food and Drug Adminis...

Y-mAbs’ Danyelza injection receives marketing approval ...

Danyelza will be given three times in a week to patients and the dosage will be ...

Forge Biologics joins BGTC for new AAV gene therapies d...

BGTC creates a reusable standardised method, which reduces upfront costs and dev...

Supplies of Novo Nordisk’s Wegovy starter doses to be l...

Key opinion leaders (KOLs) interviewed by GlobalData have highlighted that despi...

FDA approves breakthrough pneumonia therapy

The FDA approved Xacduro, developed by Entasis which is now a part of Innoviva, ...